PULM · NASDAQ
Pulmatrix (PULM) Stock Price & Fundamentals
Pulmatrix (PULM) closed at $349.44 on Oct 9, 2026, down 0.99% from the previous close of $352.93.
Share price, past year
1Y +19.41%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $349.44 |
| Sep 30, 2026 | $348.17 |
| Aug 31, 2026 | $344.88 |
| Jul 31, 2026 | $336.55 |
| Jun 30, 2026 | $327.61 |
| May 29, 2026 | $341.72 |
| Apr 30, 2026 | $345.48 |
| Mar 31, 2026 | $359.94 |
| Feb 27, 2026 | $343.83 |
| Jan 30, 2026 | $334.41 |
| Dec 31, 2025 | $319.40 |
| Nov 28, 2025 | $299.48 |
| Oct 31, 2025 | $288.66 |
Key statistics
- Market cap
- $1.28B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.10
- Revenue (TTM)
- —
- Net income (TTM)
- −$4.01M
- Shares outstanding
- 3.7M
- Dividend yield
- —
- 52-week range
- $281.88 – $365.86
Pulmatrix's market cap is $1.28B, based on a share price of $349.44 and 3.7M shares outstanding as of Jun 30, 2026.
Financials
Pulmatrix reported revenue of $7.81M for fiscal 2024, up 6.96% from fiscal 2023.
Pulmatrix reported a net loss of $5.16M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $7.81M | +7.0% | −$9.56M | −122.5% | −$2.62 | −$11.11M |
| FY2023ended Dec 31, 2023 | $7.30M | +20.2% | −$14.12M | −193.5% | −$3.87 | −$16.66M |
| FY2022ended Dec 31, 2022 | $6.07M | +17.5% | −$18.84M | −310.3% | −$5.46 | −$19.44M |
| FY2021ended Dec 31, 2021 | $5.17M | −59.1% | −$20.17M | −390.2% | −$8.63 | −$19.87M |
| FY2020ended Dec 31, 2020 | $12.63M | +59.7% | −$19.31M | −152.8% | −$13.43 | −$12.76M |
| FY2019ended Dec 31, 2019 | $7.91M | +5,069.9% | −$20.60M | −260.4% | −$1.23 | $3.17M |
| FY2018ended Dec 31, 2018 | $153.00K | −54.3% | −$20.56M | −13,439.9% | −$4.98 | −$16.78M |
| FY2017ended Dec 31, 2017 | $335.00K | −59.9% | −$18.06M | −5,389.9% | −$9.32 | −$14.55M |
| FY2016ended Dec 31, 2016 | $835.00K | — | −$27.84M | −3,334.5% | −$1.88 | — |
| FY2015ended Mar 31, 2015 | $0.00 | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2024ended Dec 31, 2024 | $3.00K | −$1.99M | −$0.55 |
| Q3 FY2024ended Sep 30, 2024 | $366.00K | −$2.59M | −$0.71 |
| Q2 FY2024ended Jun 30, 2024 | $1.55M | — | — |
| Q1 FY2024ended Mar 31, 2024 | $5.89M | — | — |
| Q4 FY2023ended Dec 31, 2023 | $2.20M | — | — |
| Q3 FY2023ended Sep 30, 2023 | $1.75M | — | — |
| Q2 FY2023ended Jun 30, 2023 | $1.84M | — | — |
| Q1 FY2023ended Mar 31, 2023 | $1.50M | — | — |
Company profile
- Name
- Pulmatrix, Inc.
- Ticker
- PULM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 945 Concord Street, Suite 1217, Framingham, MA 01701
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001574235
Recent SEC filings
- Aug 13, 2026
- Aug 13, 2026
- Jun 16, 2026
- May 15, 2026
- May 15, 2026
- Apr 21, 2026
- Mar 27, 2026
- Mar 2, 2026
Frequently asked questions
What is Pulmatrix's stock price?
Pulmatrix (PULM) closed at $349.44 on Oct 9, 2026, down 0.99% from the previous close of $352.93.
What is Pulmatrix's market cap?
Pulmatrix's market cap is $1.28B, based on a share price of $349.44 and 3.7M shares outstanding as of Jun 30, 2026.
How much revenue does Pulmatrix make?
Pulmatrix reported revenue of $7.81M for fiscal 2024, up 6.96% from fiscal 2023.
Does Pulmatrix pay a dividend?
Pulmatrix's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Pulmatrix, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures